Event Abstract

The role of serotonin and acetylcholine in mismatch negativity generation

  • 1 Department of Neuropsychology and Psychopharmacology, Maastricht University , Netherlands
  • 2 BioMag Laboratory, Helsinki University Central Hospital , Finland

Previous research has revealed that both cholinergic (ACh) and serotonergic (5-HT) manipulations not only affect mismatch negativity (MMN) amplitude, but may also be involved in novelty processing, as measured with P3a and P3b components. It is not yet clear to which extent ACh interacts with 5-HT in this matter. In a series of experiments, we examined whether MMN and P3a would decrease after lowering either ACh or 5-HT, and furthermore, whether this impairment could be reversed by increasing the other neurotransmitter, the latter manipulation indicating a possible interaction between the two neurotransmitters. We used scopolamine and biperiden (decrease ACh levels), acute tryptophan depletion (decreases 5-HT), rivastigmine (increases ACh), citalopram (increases 5-HT), and placebo treatments. In each study, a novelty oddball task was presented, which consisted of frequent standard, infrequent frequency deviants and infrequent novelty deviants (stimulus duration 300 ms and inter-stimulus interval 700 ms). The results of these studies will be used to interpret the role of ACh and 5-HT in MMN and P3a generation.

Conference: MMN 09 Fifth Conference on Mismatch Negativity (MMN) and its Clinical and Scientific Applications, Budapest, Hungary, 4 Apr - 7 Apr, 2009.

Presentation Type: Oral Presentation

Topic: Abstracts

Citation: Sambeth A, Blokland A, Kähkönen S and Riedel WJ (2009). The role of serotonin and acetylcholine in mismatch negativity generation. Conference Abstract: MMN 09 Fifth Conference on Mismatch Negativity (MMN) and its Clinical and Scientific Applications. doi: 10.3389/conf.neuro.09.2009.05.072

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 24 Mar 2009; Published Online: 24 Mar 2009.

* Correspondence: Anke Sambeth, Department of Neuropsychology and Psychopharmacology, Maastricht University, 6200 MD Maastricht, Netherlands, anke.sambeth@psychology.unimaas.nl